GSK argues against taking Teva 'skinny' label suit to SCOTUS
GSK has once again asked the Supreme Court not to hear its case with Teva over so-called “skinny” labels, meaning a generic is only approved …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
